At a glance
- Originator Amersham
- Class Cardiotonics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 07 Sep 2006 Discontinued - Preclinical for Heart failure in Austria (unspecified route)
- 31 Jul 1998 Preclinical development for Heart failure in Austria (Unknown route)